Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 20261 - 20280 out of 496039 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Australia | (H01CB02) octreotide (adm: P) | Octreotide (GH) 500 microgram/mL injection, 5 x 1 mL ampoules | Injection 500 micrograms (as acetate) in 1 mL, 5 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | GenericHealthPtyLtd |
Australia | (H01CB02) octreotide (adm: P) | Octreotide (Sun) 100 microgram/mL injection, 5 x 1 mL ampoules | Injection 100 micrograms (as acetate) in 1 mL, 5 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SunPharmaANZPtyLtd |
Australia | (H01CB02) octreotide (adm: P) | Octreotide (Sun) 50 microgram/mL injection, 5 x 1 mL ampoules | Injection 50 micrograms (as acetate) in 1 mL, 5 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SunPharmaANZPtyLtd |
Australia | (H01CB02) octreotide (adm: P) | Octreotide (Sun) 500 microgram/mL injection, 5 x 1 mL ampoules | Injection 500 micrograms (as acetate) in 1 mL, 5 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SunPharmaANZPtyLtd |
Australia | (H01CB02) octreotide (adm: P) | Octreotide Acetate (Omega) 100 microgram/mL injection, 5 x 1 mL vials | Injection 100 micrograms (as acetate) in 1 mL (S19A), 5 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | GenericHealthPtyLtd |
Australia | (H01CB02) octreotide (adm: P) | Octreotide Acetate (Omega) 50 microgram/mL injection, 5 x 1 mL vials | Injection 50 micrograms (as acetate) in 1 mL (S19A), 5 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | GenericHealthPtyLtd |
Australia | (H01CB02) octreotide (adm: P) | Octreotide Acetate (Omega) 500 microgram/mL injection, 5 x 1 mL vials | Injection 500 micrograms (as acetate) in 1 mL, 5 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | GenericHealthPtyLtd |
Australia | (H01CB02) octreotide (adm: P) | Sandostatin 100 microgram/mL injection, 5 x 1 mL ampoules | Injection 100 micrograms (as acetate) in 1 mL, 5 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsAustraliaPtyLimited |
Australia | (H01CB02) octreotide (adm: P) | Sandostatin 50 microgram/mL injection, 5 x 1 mL ampoules | Injection 50 micrograms (as acetate) in 1 mL, 5 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsAustraliaPtyLimited |
Australia | (H01CB02) octreotide (adm: P) | Sandostatin 500 microgram/mL injection, 5 x 1 mL ampoules | Injection 500 micrograms (as acetate) in 1 mL, 5 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsAustraliaPtyLimited |
Australia | (H01CB02) octreotide (adm: P) | Sandostatin LAR (1 x 10 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Injection (modified release) 10 mg (as acetate), vial and diluent syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsAustraliaPtyLimited |
Australia | (H01CB02) octreotide (adm: P) | Sandostatin LAR (1 x 10 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Injection (modified release) 10 mg (as acetate), vial and diluent syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsAustraliaPtyLimited |
Australia | (H01CB02) octreotide (adm: P) | Sandostatin LAR (1 x 20 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Injection (modified release) 20 mg (as acetate), vial and diluent syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsAustraliaPtyLimited |
Australia | (H01CB02) octreotide (adm: P) | Sandostatin LAR (1 x 20 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Injection (modified release) 20 mg (as acetate), vial and diluent syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsAustraliaPtyLimited |
Australia | (H01CB02) octreotide (adm: P) | Sandostatin LAR (1 x 30 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Injection (modified release) 30 mg (as acetate), vial and diluent syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsAustraliaPtyLimited |
Australia | (H01CB02) octreotide (adm: P) | Sandostatin LAR (1 x 30 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Injection (modified release) 30 mg (as acetate), vial and diluent syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsAustraliaPtyLimited |
Australia | (H01CB02) octreotide (adm: P) | Sandostatin LAR (1 x 30 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Injection (modified release) 30 mg (as acetate), vial and diluent syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsAustraliaPtyLimited |
Australia | (H01CB02) octreotide (adm: P) | Sandostatin LAR (1 x 30 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Injection (modified release) 30 mg (as acetate), vial and diluent syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsAustraliaPtyLimited |
Australia | (H01CB03) lanreotide (adm: P) | Mytolac 120 mg/0.5 mL injection, 0.5 mL syringe | Injection 120 mg (as acetate) in single dose pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AmdipharmMercury(Australia)PtyLimited |
Australia | (H01CB03) lanreotide (adm: P) | Mytolac 120 mg/0.5 mL injection, 0.5 mL syringe | Injection 120 mg (as acetate) in single dose pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AmdipharmMercury(Australia)PtyLimited |